Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2019-08-08 Director's Dealing
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Others' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific share transactions by company executives (e.g., Choi In-seok) and provides a comprehensive table of share ownership for major shareholders and related parties. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company directors and executives.
2019-08-08 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific number of shares disposed of, the disposal price, the date of disposal, and the remaining treasury share holdings. This falls under the category of a company reporting the sale or buyback of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2019-08-07 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Yuyu Pharma regarding the decision to dispose of treasury shares (자기주식 처분 결정). This filing details the specific number of shares, the purpose (stock grant for employees), and the method of disposal. In the context of financial filings, a company's decision to sell or dispose of its own shares is classified as 'Transaction in Own Shares'.
2019-07-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition of shares/convertible bonds by Rhinos Asset Management in Yuyu Pharma. This type of filing is a mandatory regulatory disclosure regarding significant ownership changes and does not fit into specific categories like earnings releases, annual reports, or proxy statements. Therefore, it is classified as a Regulatory Filing (RNS).
2019-05-27 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Yuyu Pharma (주식회사 유유제약) for the first quarter of 2019 (제 80기 1분기). It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose their shareholdings and changes therein. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of share transactions or ownership status by company directors and executives.
2019-05-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.